Normalized claim
Time: 73% increase
clinicians could detect 73 percent of patient deterioration events within 24 hours
BioIntelliSense: Using AWS (EC2 + Bedrock) for proactive clinical deterioration detection and patient summaries
Use case typeClinical decision supportUpdated Jun 13, 2026
BioIntelliSense is a Denver-based digital health startup that provides patient monitoring and clinical intelligence for hospitals and home care. Its BioButton wearable captures vital signs continuously and transmits them to the BioCloud platform and BioDashboard for near real-time insights. The company plans to use Amazon Bedrock with Anthropic Claude to generate summaries of patients’ medical histories for nurses in BioDashboard.
- Organization
- BioIntelliSense
- Industry
- Healthcare
- Location
- United States
- Published
- May 2026
Reported outcomes
9 hours
timeTime & speed
+73%time−50%time1 notification/dayquantified impact
Strategic outcomes
New product / capabilityEnabled continuous vital-sign monitoringBetter decisions & insightImproved early deterioration detectionNew product / capabilityPlanned nurse medical-history summaries
Why do we believe this?Outcome claims, sources, and evidence checks
Normalized claim
Time: 50% decrease
nurses spent 50 percent less time taking vital signs
Normalized claim
Time: 9 hours decrease
reduced the average length of stay ... by 9 hours over 15 months
Normalized claim
Quantified impact: 1 notification/day decrease
reduced the volume of notifications to fewer than one notification per patient per day
Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
- Customer
- BioIntelliSense
- Provider
- AWS
- Maturity
- Unknown
- Linked source
- AWS Customer Stories
No explicit deployment-stage evidence found.
Customer identity supportedSource describes one deploymentMaturity evidence evaluated
Primary read
Use case focus
Showing 3 of 3
- 1Patient monitoring
- 2Clinical decision support
- 3Generative AI summarization
- Hospitals faced cost and staffing burdens from manual, intermittent vital-sign checks.
- They needed earlier detection of clinical deterioration and lower nursing notification burden.
- The company also wanted to streamline clinician review of patient histories.
- BioButton captures up to 1,440 measurements per patient per day and transmits data to BioCloud.
- AI detects patterns in vital signs to inform proactive clinical interventions and display trends in BioDashboard.
- BioDashboard runs on Amazon EC2, and BioIntelliSense plans to use Amazon Bedrock and Claude to create medical-history summaries for nurses.
Technologies
- Clinicians could detect 73% of patient deterioration events within 24 hours in a retrospective study.
- Notifications were reduced to fewer than one per patient per day.
- Nurses spent 50% less time taking vital signs.
- Average length of stay was reduced by 9 hours over 15 months.
Architecture
BioButton wearable captures patient vital signs and sends them to the BioCloud platform. BioDashboard runs on Amazon EC2 for clinician review, and the company plans to use Anthropic Claude in Amazon Bedrock to generate medical-history summaries for nurses. The article also references AWS as the underlying cloud platform for secure, compliant patient monitoring.
Sources & evidence1
Evidence: Medium50/100Evidence strength
- Customer explicitly identified
- Primary source available
- Quantified outcome available
- Technical implementation details available
Type: Customer StoryPublished: May 27, 2026Publisher: AWSEvidence: PrimaryConfidence: High
AI-generated summary. Verify important details with the linked sources before relying on this case.
Explore related AI use cases
Customer evidence
Provider evidence
Browse the catalog
Was this useful?
Community
Comments
No published comments yet.